---
title: "Briefly outline the pharmacology of the following anti-platelet agents (i) aspirin, (ii) clopidogrel, (iii) ticagrelor, (iv) tirofiban using the following headings • mechanism of action • important pharmacokinetics • duration of effect"
entityType: SAQ
exam: PEX
college: ANZCA
year: 2023
sitting: B
question: 13
passRate: 54
EC_expectedDomains:
- "the answer should have been structured as directed by the question"
- "to pass, candidates needed to cover two or three drugs, depending on the completeness of the answer"
EC_extraCredit:
- "breadth of answer, including information about all 4 drugs"
- "detail in answer"
- "nuanced answer with clinical context"
EC_errorsCommon:
- "confusing half life and duration of action (this group of drugs demonstrates that these concepts may be completely unrelated)"
- "some candidates answered clopidogrel and ticagrelor together under the same heading – there are important differences between these two drugs"
- "no candidate explained the apparent discrepancy between ticagrelor’s half life and reversible binding, and its duration of effect"
- "not mentioning the effect of genetic polymorphism on clopidogrel"
- "aspirin should not be described as a prodrug"
---